Growth and insulin-like growth factors (IGFs) in children with insulin-dependent diabetes mellitus at the onset of disease: Evidence for normal growth, age dependency of the IGF system alterations, and presence of a small (approximately 18-kilodalton) IGF-binding protein-3 fragment in serum

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 11, 2000, Pages 4162-4167

  Cianfarani, Stefano ^a   Bonfanti, Riccardo ^b   Manca Bitti, Maria Luisa ^a   Germani, Daniela ^a   Boemi, Sergio ^c   Chiumello, Giuseppe ^b   Boscherini, Brunetto ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c S EUGENIO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 3;

ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY HEIGHT; CHILD; CHILD GROWTH; CONTROLLED STUDY; DIABETOGENESIS; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; METABOLISM; ONSET AGE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SCHOOL CHILD;

EID: 0034530878     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.85.11.6996     Document Type: Article

References (44)

1. Growth development and prognosis of diabetic children
2. Height at diagnosis of diabetes in children: A study in identical twins
3. Height at diagnosis in diabetes
4. Longitudinal data on growth and final height in diabetic children
5. Growth of children with insulin-dependent diabetes. Study of 104 cases
6. Height and skeletal maturity in children with newly-diagnosed juvenile-onset diabetes
7. Height at diagnosis of insulin dependent diabetes in patients and their non-diabetic family members
8. Growth and growth factors in diabetes mellitus
9. Growth of children before onset of diabetes
10. Growth changes in children and adolescents with short-term diabetes
11. Increased height in diabetes mellitus corresponds to the predicted and the adult height
12. Growth during childhood and final height in type 1 diabetes
13. Insulin-like growth factors and their binding proteins
14. Effect of diabetes and its control on insulin-like growth factors in the young subject with type-1 diabetes
15. Somatomedin-C/IGF-I measured by radioimmunoassay and somatomedin bioactivity in adolescents with insulin-dependent diabetes compared with puberty matched controls
16. Effect of insulin on the insulin-like growth factor system in children with new-onset insulin-dependent diabetes mellitus
17. Insulin-like growth factor (IGF)-I and -II and IGF-binding proteins-1, -2, and -3 in children and adolescents with diabetes mellitus: Correlation with metabolic control and height attainment
18. Normal stimulated growth hormone but low peripheral levels of insulin-like growth factor 1 in prepubertal children with insulin-dependent diabetes mellitus
19. Insulin-like growth factor-I, its binding proteins-1, and -3, and growth hormone binding protein in children and adolescents with insulin-dependent diabetes mellitus: Clinical implications
20. Serum insulin-like growth factor II levels in normal adolescents and those with insulin-dependent diabetes mellitus
21. Growth hormone-binding proteins, IGF-I and IGF-binding proteins in children and adolescents with type 1 diabetes mellitus
22. Insulin-like growth factors: Studies in diabetes with and without retinopathy
23. Radioimmunoassay of growth hormone-dependent insulin-like growth factor binding protein in human plasma
24. Abnormal regulation of insulin-like growth factor binding proteins in adolescents with insulin-dependent diabetes
25. Serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in children with insulin-dependent diabetes mellitus
26. Insulin-like growth factor binding protein-3 proteolysis in children with insulin-dependent diabetes mellitus: A possible role for insulin in the regulation of IGFBP-3 protease activity
27. Alterations in the growth hormone-insulin-like growth factor axis in insulin dependent diabetes mellitus
28. Regulation of the insulin-like growth factor system by acute acidosis
29. Clinical longitudinal standards for height, weight, height velocity, weight velocity and staged of puberty
30. Goiter prevalence and urinary excretion of iodine in a sample of school age children in the city of Rome
31. Intrauterine growth retardation: Evidence for the activation of the insulin-like growth factor (IGF)-related growth-promoting machinery and the presence of a cation-independent IGF binding protein-3 proteolytic activity by two months of life
32. Expression of insulin-like growth factor I in cultured rat hepatocytes: Effects of insulin and growth hormone
33. Insulin and growth hormone act synergistically to stimulate insulin-like growth factor-I production by cultured chicken hepatocytes
34. Insulin regulates insulin-like growth factor I mRNA in rat hepatocytes
35. In-vivo regulation of messenger RNA encoding insulin-like growth factor-I (IGF-I) and its receptor by diabetes, insulin and IGF-I in rat muscle
36. Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1 and IGFBP-3
37. Glucose does not influence the insulin-like growth factor (IGF) binding to carrier proteins (IGFBPs): Analysis of rat and human serum by western ligand blotting
38. Characterization of a low molecular mass form of insulin-like growth factor binding protein-3 (17.7 kilodaltons) in urine and serum from healthy children and growth hormone deficient patients: Relationship with GH therapy
39. Evaluation of the components of insulin-like growth factor (IGF)-IGF binding protein (IGFBP) system in adolescents with type 1 diabetes and persistent microalbuminuria: Relationship with increased urinary excretion of IGFBP-3 18 kDa N-terminal fragment
40. The induction of specific protease for insulin-like growth factor binding proteins following major heart surgery
41. The effect of dietary protein supplementation on insulin-like growth factors and IGF binding proteins in children with shigellosis
42. Increased proteolysis of insulin-like growth factor binding protein-3 (IGFBP-3) in noninsulin-dependent diabetes mellitus serum, with elevation of a 29 kDa glycosylated IGFBP-3 fragment contained in the approximately 130- to 150-kDa ternary complex
43. Postoperative induction of insulin-like growth factor binding protein-3 proteolytic activity: Relation to insulin and insulin sensitivity